Next Article in Journal
Integration of Systemic Therapy and Stereotactic Radiosurgery for Brain Metastases
Next Article in Special Issue
Survival of Patients with Epidermal Growth Factor Receptor-Mutated Metastatic Non-Small Cell Lung Cancer Treated beyond the Second Line in the Tyrosine Kinase Inhibitor Era
Previous Article in Journal
The Role of DND1 in Cancers
Previous Article in Special Issue
Early Progression in Non-Small Cell Lung Cancer (NSCLC) with High PD-L1 Treated with Pembrolizumab in First-Line Setting: A Prognostic Scoring System Based on Clinical Features
 
 
Article

Article Versions Notes

Cancers 2021, 13(15), 3681; https://doi.org/10.3390/cancers13153681
Action Date Notes Link
article xml file uploaded 22 July 2021 11:25 CEST Original file -
article xml uploaded. 22 July 2021 11:25 CEST Update -
article pdf uploaded. 22 July 2021 11:25 CEST Version of Record https://www.mdpi.com/2072-6694/13/15/3681/pdf-vor
article html file updated 22 July 2021 11:26 CEST Original file -
article pdf uploaded. 10 August 2021 03:24 CEST Updated version of record https://www.mdpi.com/2072-6694/13/15/3681/pdf
article xml uploaded. 10 August 2021 03:24 CEST Update https://www.mdpi.com/2072-6694/13/15/3681/xml
article html file updated 10 August 2021 03:25 CEST Update -
article html file updated 27 July 2022 05:57 CEST Update https://www.mdpi.com/2072-6694/13/15/3681/html
Back to TopTop